Cargando…

Hepatitis B core‐related antigen levels predict recurrence‐free survival in patients with HBV‐associated early‐stage hepatocellular carcinoma: results from a Dutch long‐term follow‐up study

Prognosis of hepatitis B (HBV)‐associated hepatocellular carcinoma (HCC) is poor due to high rates of HCC recurrence and progression of underlying liver disease. We studied whether serum hepatitis B core‐related antigen (HBcrAg) levels could predict HCC recurrence and outcome in HBV associated. High...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beudeker, Boris J. B., Groothuismink, Zwier M. A., de Man, Robert A., Witjes, Caroline D. M., van der Eijk, Annemiek A., Boonstra, Andre, Sonneveld, Milan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756674/ https://www.ncbi.nlm.nih.gov/pubmed/32869922 http://dx.doi.org/10.1111/jvh.13394

Ejemplares similares

Circulating Cytokines Reflect the Etiology-Specific Immune Environment in Cirrhosis and HCC
por: Beudeker, Boris J. B., et al.
Publicado: (2022)

Letter to the Editor: Entecavir Treatment Restores the Anti‐HBV Immune response?
por: Beudeker, Boris J.B., et al.
Publicado: (2021)

Monocytes from Chronic HBV Patients React In Vitro to HBsAg and TLR by Producing Cytokines Irrespective of Stage of Disease
por: Boltjes, Arjan, et al.
Publicado: (2014)

Circulating biomarkers for early detection of hepatocellular carcinoma
por: Beudeker, Boris J. B., et al.
Publicado: (2020)

Levels of Antibodies to Hepatitis B Core Antigen Are Associated With Liver Inflammation and Response to Peginterferon in Patients With Chronic Hepatitis B
por: Brakenhoff, Sylvia M, et al.
Publicado: (2022)

Immune dissociation during acute hepatitis E infection
por: Debes, Jose D., et al.
Publicado: (2019)

Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and HCV/HIV Co-Infection and Do Not Recover during Therapy
por: Spaan, Michelle, et al.
Publicado: (2016)

ITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV Infection
por: Maan, Raoel, et al.
Publicado: (2015)

A mutation in the progesterone receptor predisposes to HEV infection in HIV‐positive patients
por: Debes, Jose D., et al.
Publicado: (2018)

Validation and optimization of AFP-based biomarker panels for early HCC detection in Latin America and Europe
por: Beudeker, Boris J.B., et al.
Publicado: (2023)

Differential gene expression, irrespective of circulating Hepatitis B Surface Antigen levels, between Inactive Carrier and Nucleos(t)ide Analogue-Treated Hepatitis B Virus patients
por: Montanari, Noé R, et al.
Publicado: (2020)

Hepatitis B virus RNA decline without concomitant viral antigen decrease is associated with a low probability of sustained response and hepatitis B surface antigen loss
por: Brakenhoff, Sylvia M., et al.
Publicado: (2020)

Negative Regulation of Hepatitis C Virus Specific Immunity Is Highly Heterogeneous and Modulated by Pegylated Interferon-Alpha/Ribavirin Therapy
por: Claassen, Mark A. A., et al.
Publicado: (2012)

HCV antigen instead of RNA testing to diagnose acute HCV in patients treated in the Dutch Acute HCV in HIV Study
por: Hullegie, Sebastiaan J., et al.
Publicado: (2017)

Assessment of STAT4 Variants and Risk of Hepatocellular Carcinoma in Latin Americans and Europeans
por: Ayoub, Alan, et al.
Publicado: (2023)

MBOAT7 rs641738 Variant Is Not Associated with an Increased Risk of Hepatocellular Carcinoma in a Latin American Cohort
por: Goble, Spencer, et al.
Publicado: (2023)

New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?
por: Lim, Young-Suk
Publicado: (2023)

In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma
por: Zheng, Ye, et al.
Publicado: (2022)

Inhibition of the HCV Core Protein on the Immune Response to HBV Surface Antigen and on HBV Gene Expression and Replication In Vivo
por: Zhu, Wenbo, et al.
Publicado: (2012)

Recurrent HBV Integration Targets as Potential Drivers in Hepatocellular Carcinoma
por: Lin, Selena Y., et al.
Publicado: (2021)

Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells
por: Aggarwal, Abhishek, et al.
Publicado: (2022)

Characterization of HBV surface antigen isoforms in the natural history and treatment of HBV infection
por: Rodgers, Mary A., et al.
Publicado: (2023)

Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America
por: Ghany, Marc G., et al.
Publicado: (2021)

External Validation of the RETREAT Score for Prediction of Hepatocellular Carcinoma Recurrence after Liver Transplantation
por: van Hooff, Maria C., et al.
Publicado: (2022)

Evaluation of IL-28B Polymorphisms and Serum IP-10 in Hepatitis C Infected Chimpanzees
por: Verstrepen, Babs E., et al.
Publicado: (2012)

Fulminant Liver Failure due to Hepatitis B Reactivation During Treatment With Tocilizumab
por: Sonneveld, Milan J., et al.
Publicado: (2019)

Immunopeptidome of hepatocytes isolated from patients with HBV infection and hepatocellular carcinoma
por: de Beijer, Monique T.A., et al.
Publicado: (2022)

Vitamin D signaling inhibits HBV activity by directly targeting the HBV core promoter
por: Ahluwalia, Shivaksh, et al.
Publicado: (2021)

HBV Core Protein Enhances Cytokine Production
por: Kanda, Tatsuo, et al.
Publicado: (2015)

Checkpoint Inhibitors and Therapeutic Vaccines for the Treatment of Chronic HBV Infection
por: Hoogeveen, Ruben C., et al.
Publicado: (2020)

The HBV Core Protein and Core Particle Both Bind to the PPiase Par14 and Par17 to Enhance Their Stabilities and HBV Replication
por: Saeed, Umar, et al.
Publicado: (2021)

Update Treatment for HBV Infection and Persistent Risk for Hepatocellular Carcinoma: Prospect for an HBV Cure
por: Yoo, Joseph, et al.
Publicado: (2018)

Whole-genome sequencing reveals the evolutionary trajectory of HBV-related hepatocellular carcinoma early recurrence
por: Zhou, Shao-Lai, et al.
Publicado: (2022)

The Mechanisms of HBV-Induced Hepatocellular Carcinoma
por: Jiang, Yu, et al.
Publicado: (2021)

The clinical epidemiology of superficial bladder cancer. Dutch South-East Cooperative Urological Group.
por: Kiemeney, L. A., et al.
Publicado: (1993)

Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.
por: White, Y. S., et al.
Publicado: (1990)

Cancer immunotherapy with multiple tumor antigen activated autologous T cells in patients with HBV related hepatocellular carcinoma
por: Han, Yanyan, et al.
Publicado: (2014)

Expression of oncofetal antigen glypican-3 associates significantly with poor prognosis in HBV-related hepatocellular carcinoma
por: Wang, Li, et al.
Publicado: (2016)

Quasispecies variant of pre-S/S gene in HBV-related hepatocellular carcinoma with HBs antigen positive and occult infection
por: Hatazawa, Yuri, et al.
Publicado: (2018)

Molecular Mechanisms and Animal Models of HBV-Related Hepatocellular Carcinoma: With Emphasis on Metastatic Tumor Antigen 1
por: Li, Yung-Tsung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b16ttfagh0endlcpvaoor17p3v